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ABSTRACT  
Obesity encapsulates the increased risk of disease and premature death associated with excess fat, 
but it is usually measured using a simple function of weight and height known as the Body Mass 
Index (BMI).   Economists  use the BMI  to determine the prevalence of obesity within the 
population, to estimate the “disease burden” created by obesity, to establish the additional 
medical spending attributable to obesity, and to measure the current and potential effects of 
government policy on obesity.  Estimates will be biased if the measurement error from using BMI 
to proxy for obesity is correlated with other covariates.  In this paper we use a flexible function of 
percent body fat and several metabolic factors to construct an obesity index to predict death and 
disease.  We use this index to show that using BMI leads researchers to misattribute obesity-
related health outcomes to other factors such as aging, family health history, alcohol 
consumption, and household income.  Moreover, we show how these biases necessarily generate 
the opposite implications for studies on the causes of obesity.  Specifically, using BMI leads 
researchers to underestimate the effects of aging, family history of diabetes, alcohol consumption, 
and household income on obesity.  We find no significant evidence of measurement error bias 
associated with smoking or insomnia.  We also show that, compared with our obesity index, BMI 
generates substantially more false negative predictions of diabetes. 
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I.  Introduction 
The medical community has broadly recognized that the body mass index (BMI) poorly 
measures an individual’s fat content (adiposity) (Garn, Leonard, and Hawthorne, 1986; Smalley 
et al., 1990; Gallagher et al., 1996; Deurenberg, 2001; Frankenfield et al., 2001; Prentice and 
Jebb, 2001).  But BMI is easy to measure: it equals the ratio of weight in kilograms to the square 
of height in meters.
1  This simplicity makes BMI an appealing and popular gauge of adiposity 
and overall health “even though it is as much a measure of Lean Body Mass as it is a measure of 
fatness or obesity” (Garn, Leonard, and Hawthorne, 1986, p. 997).  BMI is the predominant 
instrument that both medical clinicians and researchers use for classifying individuals into 
obesity categories, to determine the prevalence of obesity within the population, and to estimate 
the “disease burden” created by obesity.
2
For similar reasons, BMI has also become the main measure of obesity and related health 
outcomes used by economists.  Several authors have attempted to estimate the effects on BMI 
resulting from participation in the Food Stamp Program (Gibson, 2003; Chen, Yen, and 
Eastwood, 2005; Meyerhoefer and Pylypchuk, 2008).  Others have used BMI in studies of the 
relationships between obesity and factors such as the number of fast-food restaurants, time spent 
preparing meals, cigarette taxes, second-hand smoke laws, and U.S. farm policy (Carter, Glaeser, 
and  Shapiro, 2003; Rashad, Grossman, and Chou, 2005; Alston, Sumner, and Vosti, 2008; 
Dunn, 2008; Anderson and Matsa, 2009).  Also, BMI-defined obesity categories are used to 
estimate the direct and indirect costs attributable to obesity, the difference in medical 
   
                                                 
1 In the studies mentioned above and throughout this paper, we use the term BMI to refer to this most commonly 
used formula.  Smalley et al. (1990) discuss several other weight-to-height BMI formulas that have been proposed 
as alternatives.    
2 Throughout this paper we use the terms “obesity” and “obese” generically, to refer to both the overweight and the 
obese, as well as specifically, in context, to distinguish between “obese” and “overweight” as different categories of 
obesity.  2 
     
expenditures for obese and overweight people compared with normal individuals, and the share 
of the growth in medical spending attributable to an increased prevalence of obesity. 
In this paper we quantify the implications of using BMI to estimate the causes and effects 
of obesity.  Standard econometric theory implies that measurement error generates bias 
depending on the correlation between the measurement error and the explanatory variables in a 
regression model (Fuller, 1987; Bound and Kreuger, 1991); estimates of the causes and effects of 
obesity could be quite erroneous when this correlation is high.  For example, if BMI has a greater 
measurement error for the average heavy drinker of alcohol than for the rest of the population, a 
finding that heavy drinking predicts lower BMI may merely reflect prediction of the 
measurement error. 
We build on a few recent papers that have addressed the drawbacks of BMI in economic 
research.  Burkhauser and Cawley (2008) pointed out the substantial differences between BMI 
and percent body fat (%BF) in measuring obesity.  They also found a negative correlation 
between employment and total body fat, but no significant correlation between fat-free mass and 
employment.  This difference was obscured in previous papers that measured obesity using BMI. 
Similarly, Wada and Tekin (2010) found differences in how body fat and fat-free mass correlate 
to wages, and Johansson et al. (2009) concluded that labor market underperformance associated 
with obesity may be measured with bias.  
To understand measurement error and its implications, we first have to quantify obesity.  
In this paper, we define obesity conventionally, as excess fat that increases the risk of developing 
diseases such as type 2 diabetes or of dying prematurely.  We estimate the risk of such diseases 
or death and calculate an implied obesity index that depends on a person’s sex and race.  We find 3 
     
evidence of significant measurement error bias in models that use BMI as a proxy for obesity in 
determining disease and mortality risk. 
II.  Quantifying Obesity: Background 
An obese individual has a relatively high risk of disease and premature death attributable 
to excess fat (Allison et al., 1999; US DHHS, 2001; Flegal et al., 2007; Prospective Studies 
Collaboration, 2009).  Quantifying excess fat is difficult, but medical researchers have begun to 
uncover the fundamental mechanisms behind the development of obesity and the underlying 
changes that link obesity to specific diseases. We begin by summarizing these mechanisms to 
provide context for our analysis. 
A.  Mechanisms Linking Obesity, Morbidity, and Mortality 
Obesity exacerbates or contributes to numerous co-morbidities and diseases including 
stroke, cardiovascular disease, peripheral artery disease, colon cancer, postmenopausal breast 
cancer, various musculoskeletal conditions (e.g., osteoarthritis), gallbladder disease, and type 2 
diabetes, among others (Must et al., 1999; US DHHS, 2001; Flegal et al., 2007).
 3  Adipocytes 
(i.e., fat cells), are an “organ” of the endocrine system, secreting “a number of bioactive 
mediators that influence not only body weight homeostasis but also insulin resistance   . . . lipids, 
blood pressure, coagulation, fibrinolysis and inflammation . . .” (Van Gaal, Mertens, and De 
Block, 2006).
4
                                                 
3 A co-morbidity is “A medical condition that exists in addition to, and is caused or worsened by, obesity or any 
other primary disease being studied or treated,” from: 
  These bioactive mediators, collectively known as adipokines, also respond to 
http://health.ucsd.edu/specialties/lapband/about/glossary.htm. 
4 Fibrinolysis is the natural process that breaks down blood clots and keeps blockages and other problems from 
occurring.  From: http://www.nlm.nih.gov/medlineplus/ency/article/000577.htm  4 
     
signals from the central nervous and hormone systems (Kershaw and Flier, 2004; National 
Cancer Institute, March 2004; Poirier et al., 2006). 
The metabolic and systemic abnormities associated with obesity lead to conditions such 
as the metabolic syndrome, which precedes the development of type 2 diabetes, cardiovascular 
disease (CVD), and death (American Heart Association, 2004; Kershaw and Flier, 2004).  In 
obese persons, when lipids (fats) collect in the major organs rather than in fat cells, the ensuing 
“lipotoxicity” can lead to death of the organ tissues.  Similarly, when fat accumulates around 
organs it impairs their function by secreting compounds onto them, compressing them into less 
space, or both (Poirier et al., 2006).  Figure 1 illustrates the biological mechanisms that underlie 
the links between obesity, vascular disease, type 2 diabetes, and some cancers.  
[Figure 1: Mechanics of Excess Adipose Tissue and Disease Risk] 
Medical research has shown that the amount of fat and its distribution throughout the 
body affect health outcomes (Després et al., 1990).  In particular, it makes a significant 
difference whether fat cells are evenly dispersed throughout the body or have accumulated in and 
around the abdomen.  Abdominal fat has an especially detrimental effect, increasing the risk of 
developing insulin resistance and several types of cancer (Kannel, D’Agostino, and Cobb, 1996; 
Okosun et al., 2004).
5
                                                 
5 Central adiposity or obesity, trunk fat, belly fat, upper body fat, and android obesity are all synonyms for 
abdominal fat or adiposity.  Central adiposity is defined as “the storage of adipose tissue preferentially in adipocytes 
on or within the trunk rather than the extremities” (Calle and Kaaks, 2004).   
  Several biological mechanisms account for the role abdominal fat plays in 
raising the risk of CVD, type 2 diabetes, and cancer.  In addition, abdominal fat independently 
increases the risk of high blood pressure and low high-density-lipoprotien (HDL) or “good” 5 
     
cholesterol.
6
Aging also affects body composition and the distribution of body fat, even for those who 
maintain their body weight throughout old age.  As people get older they lose muscle mass and 
  Adipocytes also secrete sex hormones (e.g., testosterone and estrogens), which 
influence the body’s preferred locations for storing fat and how lipoprotiens metabolize.  Taken 
in combination, the metabolic effects of intra-abdominal adiposity independently increase the 
risk of CVD (Després et al., 1990; Chan et al., 2003; Okosun et al., 2004).  The elevated levels 
of estrogen in the blood stream associated with obesity significantly increase the risk of 
postmenopausal breast and endometrial cancers.  Similarly, unable to metabolize the excess 
insulin and glucose building up circulating in their blood, those with central obesity have a 
higher risk of colon and endometrial cancer, and probably a higher risk of pancreatic and renal-
cell (kidney) cancer as well.  Insulin stimulates the production of IGF-1 and both hormones 
simultaneously encourage cell growth and impede cell death, having a tumor-producing effect 
(Calle and Kaaks, 2004).  Smoking exacerbates the metabolic abnormalities that underlie the 
links between obesity, type 2 diabetes, CVD, and cancer, as evidenced by the shorter life 
expectancy of obese smokers (Van Gaal, Mertens, and De Block, 2006). 
Maternal obesity, particularly in the second and third trimesters, also appears to affect 
predisposition of progeny to obesity and type 2 diabetes through various pathways (McGanity, 
Dawson, and Hook, 1998; King, 2006).  Exposure in the womb to over-nutrition, type 2 diabetes, 
or gestational diabetes, exposure in early infancy to over-feeding, or both, can irreversibly 
“program the development of obesity and diabetes” by altering the biologic systems that regulate 
food intake, metabolism, and weight (Bouret et al., 2004; Plagemann, 2008).   
                                                 
6 An “independent risk factor” for a disease is a risk factor that is statistically significantly related to a health 
outcome, controlling for all other established risk factors. However, finding an independent risk factor is not 
equivalent to establishing causation (Brotman et al., 2005). 6 
     
height, gain fat, and have an increased predisposition to storing fat in the abdomen.  Taken in 
combination, the changes in body composition, body fat distribution, and triglyceride levels 
associated with aging could explain much of the high incidence of the Metabolic Syndrome 
(TMS) among the old (Zamboni et al., 2005; Miller, 2008).     
B.  Existing Measures of Obesity  
The previous section describes how the accumulation of excess fat in the human body 
causes disease and premature death.  Therefore, a first-order measure of obesity is the fraction of 
total body weight composed of only adipose tissue, expressed as the percent body fat.  This 
measure quantifies overall body composition by distinguishing between the share of fat and non-
fat tissues (i.e., bones, internal organs, and muscles) in total body weight: the greater the 
proportion of fat, the more obese is an individual.  However, %BF is costly and difficult to 
measure accurately.
7
The impracticality of large scale measurement and monitoring of %BF creates demand 
for simple and inexpensive measures of obesity.  The most popular such measure is the BMI, 
defined as the ratio of weight in kilograms to the square of height in meters.  The BMI had its 
genesis when the insurance industry recognized the increased mortality risk associated with 
obesity and the need for an index of “normal” body weight (Eknoyan, 2008).  The “normal” 
range for BMI of 20-25 was defined because it correlates reasonably well with the minimum risk 
of death from life insurance tables (Pi-Sunyer, 1998).  As a measure of relative weight-for-
         
                                                 
7 Body composition can be estimated using imaging techniques (e.g., Dual-Energy X-ray Absorption (DEXA), CAT 
scan, or MRI), body element assay methods (e.g., isotope 
40K counting), anthropometry (e.g., skinfold thickness or 
BMI), , and electrical conductivity techniques (bioelectrical impedance analysis (BIA)), among other techniques.  
The cost, accuracy, and ease of collecting the requisite measurements varies significantly among methods.  
Accounting for the influence of race, age, and sex, BIA accurately measures total body water (and from there, body 
fat) with a non-invasive (e.g., no radiation exposure or needle pricks), non-hazardous, and low cost device (Forbes, 
1998).   7 
     
height, epidemiologists started relying on BMI because it varies less with height or frame size 
than other anthropometric measures do, and correlates with body density (and thus body fat) at 
least as well as other indices do (Keys et al., 1972).        
Several authors have found that the common BMI inadequately predicts the amount of 
adipose tissue carried by an individual, and that general BMI cutoff points are unsuitable, 
especially for specific subpopulations (Burkhauser and Cawley, 2008; Garn, Leonard, and 
Hawthorne, 1986; Smalley et al., 1990; Gallagher et al., 1996; Deurenberg, 2001; Frankenfield 
et al., 2001; Prentice and Jebb, 2001).  Frankenfield et al. (2001) showed that BMI does a poor 
job of predicting %BF for individuals who have a BMI below the obesity threshold (i.e., BMI < 
30) and concluded that %BF is a better gauge of obesity than BMI in individuals having BMI < 
30.  Alternatives to BMI as measures of fatness include the waist-to-hip ratio (WHR), the waist-
to-height (or waist-to-stature) ratio (WHtR), and the waist circumference (WC). These measures 
are all simple to calculate. Moreover, they bring information not just on the amount of excess fat 
accumulation, but also the distribution of body fat.  
Based on the discussion in the previous section, the location of excess fat significantly 
affects the risk of obesity-related disease and premature death (Prentice and Jebb, 2001; Gelber 
et al., 2008).  Using data from the Physicians’ Health Study (PHS) and Women’s Health Study 
(WHS), Gelber et al. (2008) found that among anthropometric measures, WHtR best predicts 
cardiovascular disease (CVD).
8
                                                 
8 Gelber et al. (2008) appraised each anthropometric index based on model fit (determined by a likelihood ratio test) 
and the strength of the relationship between CVD and the index (as measured by the estimated relative risk ratio).   
  Using the Third National Health and Nutrition Examination 
Survey (NHANES III) data that we use in this paper, Janssen, Katzmarzyk, and Ross (2004) 
confirmed that WC outperforms BMI at predicting health risks associated with obesity.  They 
showed that WC (measured to the nearest 0.1 cm) significantly predicts obesity-related co-8 
     
morbidity whereas BMI (also measured as a continuous variable) does not.  That is, BMI does 
not add any information about co-morbidity risk when WC is known. 
Similarly, using longitudinal data from the Health Professionals Follow-Up Study, Wang 
et al. (2005) showed that WC (as a gauge of abdominal obesity) relative to BMI (as a measure of 
overall obesity) better represents the risk of type 2 diabetes in adult men.  As hypothesized, Chan 
et al. (2003) found that compared with BMI, WC better predicts visceral adipose tissue contained 
within and behind the abdominal cavity (i.e., the intraperitoneal and retroperitoneal regions).  
Chan et al. (2003) concluded that “in men WC is the anthropometric index that most uniformly 
predicts the distribution of adipose tissue among several fat compartments in the abdominal 
region, there apparently being little value in measuring WHR or BMI.”   
Several authors have noted that in clinical work BMI can serve as a useful gauge of 
disease risk and overall health of individual patients.  Litwin (2008) pointed out that, although 
several alternatives to BMI exist, “there is no clear consensus on how (or where) to measure 
these parameters or on defining the optimal cutoff values for normal and abnormal.”  A number 
of other obesity classification systems and cutoffs based on measures other than BMI exist, but 
are less-widely used.  Table 1 displays the obesity categories and corresponding measurement 
ranges for several alternative measures of fatness.  Table 2 shows the distribution of the adult 
population based on these alternative systems. 
[TABLE 1. Alternative Obesity Classification Systems ] 
[TABLE 2. Adult Weight Distribution by Obesity Classification System] 
Depending on the classification system, the prevalence of obesity in the NHANESIII 
survey ranges from 18 percent to 62.5 percent for adult men and from 24 percent to 75 percent 
for adult females, respectively.  Because these systems all measure fatness differently (i.e., as the 9 
     
ratio of weight to height², overall body fat, and abdominal fat) and have different criteria for 
establishing cut-off points, they paint drastically different pictures of the health status of 
American adults.  Even the %BF classification system, whose cut-off points were set to coincide 
with the standard BMI cut-off points, puts the obesity prevalence among males at 1.75 times that 
of the BMI-based system (Gallagher et al., 2000).
9
III.  How BMI is Used to Quantify Obesity and Its Consequences 
  Using the NHANES III Burkhauser and 
Cawley (2008) demonstrated that the difference in obesity prevalence between black and white 
women falls from 12 percentage points to 5 percentage points when obesity is defined as having 
a %BF of 30 percent.   
BMI and the obesity categories defined by it might not accurately reflect the current and 
potential loss of life and decline in quality of life associated with an ever-growing number of 
people carrying excess body fat.  Individuals, social scientists, and policymakers would like a 
“fatness” index and classification system that reflects the risks to health and wellbeing associated 
with carrying excess fat.  An obesity index that reflects these risks is needed especially for 
overweight children, who stand to lose the most in terms of quality and length of life (Freedman 
and Perry, 2000; Deckelbaum and Williams, 2001; Ebbeling, Pawlak, and Ludwig, 2002; Boney 
et al., 2005; Speiser et al., 2005; Weiss and Caprio, 2005; Daniels, 2006). 
The vast majority of research on obesity uses BMI to categorize people into a weight 
category (e.g., normal-, over-, or underweight).  If measurement error biases are significant, such 
                                                 
9 Gallagher et al. (2000) collected data on %BF and BMI for whites, African Americans, and Japanese and estimated 
the equation 
11
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− =α +α +α PBF BMI Age  for Japanese men and women separately.  From the estimated coefficients 
Gallagher et al. (2000) then predicted   PBF corresponding to BMI of 18.5, 25, and 30 for specific age, race, and 
gender combinations. 10 
     
use can lead to a misleading portrayal of the extent of the obesity epidemic, and biased estimates 
of its causes and costs.  The measurement error bias associated with using BMI as a proxy for 
obesity may pervade many studies.     
A.  Excess Morbidity and Mortality Associated with BMI 
Many health complications and conditions are associated with high BMI.  Using data 
from the Third National Health and Nutrition Examination Survey (NHANES III), Must et al. 
(1999) found that among co-morbidities associated with high BMI, high blood pressure (HBP) is 
the most prevalent among U.S. adults.  Their results indicate that type 2 diabetes, gallbladder 
disease, coronary heart disease and osteoarthritis are all more prevalent among those classified 
by BMI as overweight or obese and that the prevalence increases with the degree of obesity.  In 
addition, they found that the prevalence of having two or more co-morbidities increases with 
ascending BMI class.  Among co-morbidities associated with obesity, only high blood 
cholesterol (HBC) did not increase in prevalence by BMI category; however individuals with 
BMI ≥ 25 did have a higher prevalence of HBC than those with BMI < 25.     
Excess weight caused by sedentary lifestyles and unhealthy diets comes in second only 
to, and may soon surpass, cigarette smoking as the leading “actual cause of death” in the United 
States (Mokdad et al., 2004).  Published estimates indicate that individuals with a BMI ≥ 30 have 
a 50-100 percent greater risk of premature death than those within the healthy BMI range (25 ≥ 
BMI > 20) (US DHHS, 2001).
10
                                                 
10 The most commonly used BMI cutoff points are 18.5, 25, and 30 for lower bounds on the normal, overweight and 
obese categories.  A BMI of 20 is also commonly used as the lower bound on the normal category, but some medical 
studies have alternative BMI cutoff points based on the BMI distribution of the sample under investigation.   
  Allison et al. (1999) produced a conservative estimate of 11 
     
approximately 300,000 excess adult deaths per year attributable to obesity.
11
                                                 
11 The estimated number of excess deaths attributed to obesity is defined as the number of people who died in a 
given year who would not have died if they had been in the healthy BMI range at the start of the year (Allison et al., 
1999).  Allison et al. (1999) predicted excess deaths attributable to obesity in 1991 and Flegal et al. (2007) 
approximated the share of excess cause-specific deaths attributable to overweight and obesity in 2004.  
  Similarly, Flegal et 
al. (2007) used hazard rates generated from pooling the NHANES I, II, and III data to estimate 
cause-specific excess deaths attributable to overweight and obesity as defined by BMI.  They 
found excess deaths from cardiovascular disease and obesity-related cancers associated with 
BMI > 35, and excess deaths from diabetes and renal disease were linked to BMI > 25.  Jia and 
Lubetkin (2010) found that the number of healthy days of life lost from obesity has more than 
doubled, rising from 7.5 to 16.9 days of healthy life lost per adult between 1993 and 2008.   
Prospective Studies Collaboration (2009) compiled data from fifty-seven separate 
surveys and found significantly increased risk of mortality from cardiovascular disease, diabetes, 
and respiratory disease for those above the upper bound of the healthy BMI range (BMI > 25).  
Their main finding was that, for those with a BMI between 25 and 50, every 5 point increase in 
BMI over the healthy threshold implied a 30 percent increase in all-cause mortality.  They also 
estimated a 40 percent higher mortality from stroke and ischaemic heart disease and a 116 
percent higher mortality from type 2 diabetes for every 5 point increase in BMI for those who 
had BMI > 25 (Prospective Studies Collaboration, 2009).  Using data from several sources, 
including NHANES III, Fontaine et al. (2003) conducted a similar analysis and found a 1-13 
year decrease in the expected remaining years of life for 20-year-old white males with BMI>30 
relative to those with a “normal” BMI of 24.  They also found significant differences in the 
predicted years of remaining life lost between races and sexes.  12 
     
B.  Impact of Economic Variables on Obesity 
Researchers interested in the interactions between obesity and economic variables like 
price, consumer preferences, and government policy also rely heavily on BMI or weight 
categories defined by BMI as their measure of obesity.   Several authors have attempted to 
estimate the effects on BMI resulting from participation in the Food Stamp Program (FSP).
12
Rashad, Grossman, and Chou (2005) found that banning television ads for fast-food 
restaurants would reduce the numbers of children (3-11 years) and adolescents (12-18 years) 
classified as overweight by 10 and 12 percent, respectively.  Dunn (2008) found that a 10 percent 
increase from the mean in the number of fast-food eateries in a region would increase BMI by 
0.33kg/m
2 and Currie et al. (2009) found that the presence of a fast-food establishment less than 
a tenth of mile from a high school leads to a 5.2 percent increase in the percent of freshman who 
fall into the obese weight category.  However, using the presence of an interstate highway as a 
proxy for fast-food restaurant supply, Anderson and Matsa (2009) found no evidence that having 
a greater number of restaurants available in an area leads to higher obesity rates for adults.  They 
showed that even though people consume more calories at restaurants, they make up for this 
increase by eating fewer calories at meals eaten in the home, and they concluded, that health 
policy aimed at reducing obesity should not target restaurants.  Cutler, Glaeser, and Shapiro 
  
Meyerhoefer and Pylypchuk (2008) found that women who participated in the FSP had a 2.5 
percent lower chance of having a normal or under-weight BMI (i.e., BMI < 25).  Their result is 
of the same sign, yet much smaller in magnitude, than those of similar previous studies (i.e., 
Townsend et al., 2001; Gibson, 2003; Chen, Yen and Eastwood, 2005).       
                                                 
12 The US Department of Agriculture Food Stamp Program (FSP) was renamed the Supplemental Nutrition 
Assistance Program (SNAP) in October, 2008.  The FSP supplements the food budget of low income households 
with monthly benefits that can only be used to purchase food at certified retail locations.  13 
     
(2003) agreed with Anderson and Matsa (2009), noting that the growth in calorie consumption 
between the 1970s and 1990s came from the consumption of more snacks and not from higher-
calorie dinners.  
Others have used BMI in studies of the relationships between obesity and factors such as 
the number of fast-food restaurants, time spent preparing meals, cigarette taxes, second-hand 
smoke laws (Lakdawalla and Phillipson, 2002; Chou, Grossman, and Saffer, 2004; Nonnemaker 
et al., 2009).  Chou, Grossman, and Saffer (2004) explored the relationship between real food 
prices, food availability, the real price of cigarettes, and obesity.  They found that the change in 
the per-capita number of restaurants and the real price of cigarettes accounted for 60 and 20 
percent, respectively, of the growth in BMI and obesity prevalence from 1984 to 1999.  
Nonnemaker et al. (2009) expanded on Chou, Grossman, and Saffer, estimating the effect of real 
cigarette prices for never, former, and current smokers separately.  Without time and state 
specific time trends Nonnemaker et al. (2009) found the puzzling result that real cigarette prices 
(with the state real excise tax rate as an instrument) had the largest effect on the BMI for people 
who have never smoked.  However, when they included time and state-specific time trends, 
consistent with the findings of the medical literature, Nonnemaker et al. found the largest effect 
of real cigarette prices on the BMI of former smokers. 
Lakdawalla and Philipson (2002) proposed that the decline in energy expenditure and 
increase in calorie intake made possible by technological change explained 60 percent and 40 
percent, respectively, of the rise in the prevalence of obesity from 1982 to 1996.  The authors 
modeled BMI as a function of the strenuousness of an occupation, the strength needed for a 
given occupation, wages, and other individual characteristics.  They found a negative and 
significant relationship between job strenuousness and BMI. 14 
     
C.  Estimates of the Cost of Obesity 
Many authors have attempted to approximate the direct and indirect costs of obesity.  
Using the “prevalence approach” Colditz (1992) estimated that the combined indirect and direct 
economic cost of obesity in 1986 was $39.3 billion.  This translates to 5.5 percent of the total 
cost of illness in 1986.  Colditz (1992) attributed the second-largest share of the total cost of 
obesity in 1986, $11.3 billion, to non-insulin-dependent diabetes mellitus (i.e., type 2 diabetes).  
Wolf and Colditz (1998) estimated that obesity accounted for $52 billion of the direct costs of 
healthcare.  More recently using health expenditure data from the National Health Accounts 
(NHA) Finkelstein et al. (2009) estimated the direct economic cost of overweight and obesity as 
$78.5 billion (9 percent of U.S. medical expenditures) in 1998 and up to $147 billion in 2008.  
Tucker et al. (2006) demonstrated a positive relationship between overall medical spending and 
BMI, controlling for the effect of increased BMI on life expectancy, with differences in this 
relationship dependent on gender and race.  These estimates do not reflect the indirect costs 
associated with lost wages and forgone earnings because of heightened morbidity and mortality, 
and therefore they may understate the total economic cost.  Obesity and ancillary conditions 
impose a significant burden on publicly funded programs (i.e., Medicaid and Medicare), which 
pay nearly half of the medical expenditures attributed to obesity.   
In 2008 the American Diabetes Association estimated that treating type 2 diabetes in the 
United States imposed a total cost of $174 billion ($116 direct and $58 billion indirect); they 
attributed $26.9 billion of the indirect cost to premature mortality.  Conditional on the prevalence 
of high BMI staying relatively stable over the next quarter century, Huang et al. (2009) estimated 
that the number of individuals diagnosed with type 2 diabetes and the number of those with 
diabetes who are eligible for Medicare will approximately double over this time span.  They 15 
     
concluded that the number of diagnosed cases will go from about 20 to 40 million, and the 
number of individuals with the disease who are eligible for Medicare will increase from 6.5 to 
14.1 million.   
D.  BMI as an Anthropometric Index 
The World Health Organization (WHO) defined an anthropometric index as a 
“combination of measurements . . . (that) relate to body size and composition.  Sometimes this is 
the only type of relationship that can be inferred; indices should then be referred to as . . . 
nutrition or health indicators” (WHO 1995, pp. 7-8).  The WHO stressed that improper use of 
indices as indicators of nutrition or health can lead to ineffectual public health policy and 
program choices.  Anthropometric indices have several uses including identifying at-risk 
populations, determining populations for intervention, and establishing population norms and 
standards.  Overall “a good indicator is one that best reflects the issue of concern or predicts a 
particular outcome” (WHO 1995, pp. 10-12). 
The same 1995 WHO report stipulated that although the BMI cut-offs are based on the 
relationship between BMI and mortality, they do not imply targets for intervention, and they only 
serve as a useful tool to determine prevalence.  Furthermore, WHO (1995) recommended using 
BMI in combination with many other measures (e.g., related to diet, exercise, and smoking) to 
determine individual risk.  The WHO also advised against significant weight fluctuations within 
or between the healthy and overweight categories, as “weight-cycling” also relates to increases in 
morbidity and mortality risk, suggesting prevention as the preferred way to reduce the prevalence 
of obesity.  Nevertheless, WHO (1995) conceded that “the method used to establish BMI cut-off 
points has been largely arbitrary . . ..  It may therefore be necessary to revise the classification of 
overweight in terms of BMI based on health risk“ (WHO 1995, pp. 312-313).  16 
     
IV.  Characterizing the Measurement Error from Using BMI to Measure Obesity 
Percentage body fat provides a first-order approximation to obesity. We begin this 
section by presenting a framework for understanding the implications of using BMI to measure 
obesity instead of %BF.  Next, given that the medical community has yet to reach a consensus as 
to what constitutes a high or unhealthy amount of body fat, we propose a new obesity index. Our 
index reflects the increased probability of a particular health outcome attributable to excessive 
fatness. We then develop a framework for understanding the implications of using BMI in place 
of the obesity index in economic research. 
A.  Measurement Error Bias when BMI is a Proxy for %BF 
Suppose an economist aims to model the determinants of obesity and would like to 
estimate the regression model 
  % ′ =β +ε i ii BF X   (1) 
for some set of explanatory variables Xi.  However, the economist does not observe %BF, so 
instead uses BMI as the dependent variable.  Equation (2) describes the relationship between 
BMI and X,  
  ′ = γ+ i ii BMI X u   (2) 
Measurement error bias produces differences between the coefficients of interest, β, and the 
coefficients in the estimated model, γ.  
From textbook econometric theory, OLS regression of BMI on X produces consistent 
estimates of β if the measurement error is uncorrelated with X.  However, measurement error 
biases arise when X contains more or different predictive information about %BF than it does 
about BMI.  For instance, suppose BMI has a greater measurement error for the average heavy 17 
     
alcohol drinker than for the rest of the population. In this setting, a finding that heavy drinking 
predicts lower BMI may reflect prediction of the measurement error rather than prediction of 
obesity.   
Expressed in terms of regression equations, measurement error bias manifests in a 
nonzero value of δ in the following regression: 
  % ′ =α +δ +ν i i ii BF BMI X   (3) 




′′ =α γ − +δ +





BF X u X v
Xv u
X
  (4) 
where  . β = γα+δ  Because %BF and BMI are measured on different scales, the absence of 
measurement error bias implies δ = 0 or β = γα, where α denotes a scale factor.  Thus, δ 
represents the difference between the coefficient of interest, β, and the coefficient we expect to 
estimate if we use BMI in place of %BF. 
In Section VI of the paper, we run the regression (3) to assess the extent of measurement 
error bias.  Nonzero estimates of the δ coefficient on an X variable imply that regressions of BMI 
on that variable are subject to measurement error bias.  We do not address systematic 
measurement errors, such as those induced by deliberate underreporting of weight, because our 
BMI data are measured rather than self-reported.  Nonetheless, as demonstrated by Rowland 
(1990) and others, if a particular dataset relies on self-reported weight values that are 
systematically biased in a way that induces correlation with explanatory variables of interest, 
then regressions based on those data will be subject to similar measurement error biases. 18 
     
Similar measurement error problems also arise if BMI is used in place of %BF as a right-
hand-side variable. Specifically, suppose an economist wishes to estimate the equation 
  ( ) 12 % ′ =β +β +ε i i ii y X BF   (5) 
but instead uses BMI in place of %BF.  The resulting estimates of β1 and β2 will be biased if       
δ ≠ 0 in the regression in (3).  Such estimates could be correctly interpreted as measuring the 
relationship between BMI and y, but not the relationship between obesity and y.  The difference 
between these two interpretations could be significant if the estimates were used as a basis for a 
policy aimed at reducing %BF rather than BMI. 
B.  The Obesity Index and Measurement Error Bias 
The medical community has not reached a consensus as to what constitutes a high or 
unhealthy amount of body fat.  Furthermore, for a given amount of body fat, health outcomes 
may vary by race, age, and sex, and by the proportion of body fat amassed in the abdomen. 
Therefore one way to define obesity (OB) is as the increased probability of a particular health 
outcome owing to excessive fatness.  We define an indicator variable D to equal one in the event 
of a bad health outcome (e.g., death or disease) and zero otherwise.  We define two sets of 
variables that predict health outcomes: F denotes measures of fatness such as %BF and waist 
circumference, and X denotes a set of covariates. The obesity index for a particular individual i, 
is the increased risk resulting from carrying extra fat, i.e., 
  ( ) ( ) Pr 1| , Pr 1| , == −= i i ii i ii O B D FX D FX   (6) 
where  i F  signifies a healthy amount of fat. 
To implement our index, we specify the model 
  ( )
2
01 2 Pr 1| , ′ = =φ +φ +φ +θ i i i i ii ii i D FX F F X   (7) 19 
     
where the i subscripts on φ0i, φ1i, and φ2i, indicate that coefficient values may vary depending  on 
individual characteristics such as sex and race.  Because fatness as measured by Fi may affect 
health outcomes differently for people of different race and sex, the healthy amount of fatness 
() i F  may also vary by race and sex.  For example, women have greater average %BF values 
than men, yet women live longer than men.  This fact suggests that the safe body fat percentage 
for women exceeds that for men. 
  Given the model in (7), the obesity index is  
  ( ) ( )
22
12 =φ − +φ − i ii i ii i OB F F F F   (8) 
This index depends specifically on the health outcome or set of outcomes defined by D, and the 
set of control variables, X.  Measurement error from using BMI in place of OB comes from two 
sources.  First, BMI may not represent well the fatness variables in F.  Second, compared with 
OB, BMI may correlate differently with the covariates.  Thus, even if BMI = F, we would still 
have measurement error, because a high BMI may have a greater health effect for people with 
some characteristics than others (i.e., the φi coefficients can differ across individuals).  These 
measurement errors might have implications for models of the determinants of obesity and for 
models and measures of the consequences of obesity. 
As in the previous section, measurement error biases arise when X contains more or 
different predictive information about OB than it does about BMI.  Specifically, suppose an 
economist aims to estimate β in the regression 
  ′ =β +ε i ii OB X   (9) 
but uses BMI in place of OB as in (2). The analogue to the measurement error equation (3) is  
 
22
12 ( )( ) ′ =φ − +φ − =α +δ +ν i ii i ii i i i i OB F F F F BMI X   (10) 20 
     
which we re-write as 
 
22
12 12 ′ φ +φ =φ +φ +α +δ +ν ii ii ii ii i i i FF FFB M I X  (11) 
By substituting this equation into the model of disease risk in (7) we get 
  ( )
2
01 2 Pr 1 , ( )′ = =φ +φ +φ +α + δ+θ +ν i i i i ii ii i i i D F X F F BMI X   (12) 
Since  i F  may vary by individual characteristics such as race and sex, the term 
2
12 φ +φ ii ii FF is a 
function of indicators for these characteristics and is therefore redundant when we include  0 φ iin 
the equation.  Thus, we have the measurement error equation 
  ( ) 0 Pr 1 , ( )′ = =φ +α + δ+θ +ν i ii i i i i D F X BMI X   (13) 
Comparing (7) and (13), we see that measurement error bias, which is indicated by δ ≠ 0, implies 
that the coefficients on Xi  differ, depending on whether BMI or the fatness variables are used to 
predict health outcomes. For example, suppose a variable measuring alcohol consumption has a 
θ coefficient equal to zero in (7), but a negative coefficient when BMI is used to predict health 
outcomes as in (13).  Based on BMI, we may conclude that alcohol consumption causes disease 
directly, when in fact it is unrelated to disease once we control for obesity.  
Similarly to the previous section, we can write δ as the difference between the coefficient 
of interest β in (9) and the expected scaled coefficient from a regression of BMI on X, i.e., 
δ =β−γα.  This expression follows directly from substituting equation (9) into (7) and equation 
(2) into (13). In (7) and (13), the variables Xi affect Di in two ways, both indirectly through the 
obesity variables and directly.  An overestimate of the direct effect necessarily implies an 
underestimate of the indirect effect and vice versa.  To continue the example in the previous 21 
     
paragraph, suppose further that moderate alcohol consumption is uncorrelated with BMI, but is 
associated with a lower OB and therefore a lower diabetes risk.  Using BMI, moderate alcohol 
would appear to have a direct negative effect on diabetes risk but no such effect on obesity when 
in fact alcohol consumption relates directly to obesity but not to diabetes.  Thus, if we observe δ 
< 0, then it means that using BMI leads to downward bias in the direct effect of the associated 
variable on health outcomes and upward bias in the effect of that variable on obesity.  Because 
the OB index is unobservable, we estimate δ as the difference between the coefficients on X in 
equations (7) and (13).  Figure 2 illustrates the sign of the bias implied when we estimate δ  > 0.   
[FIGURE 2 .  Interpretation of Measurement Error Bias when δ > 0] 
V.  Data 
We use the publically available NHANES III data and the many variables therein to carry 
out our statistical analysis.  These data contain detailed personal characteristics and medical 
information for a nationally representative sample of individuals in the United States.  We 
control for the complex survey design and sampling procedures using the sample weights and 
error estimating procedures recommended in the NHANES III analytical guide.  A detailed 
description of the data and the adjustments we make to control for the survey structure follows.        
A.  NHANES III Data 
Our data are from NHANES III, a periodic survey carried out between 1988 and 1994 by 
the National Center for Health Statistics (NCHS) and the Centers for Disease Control and 
Prevention (CDC).  NHANES III contains details on household and individual characteristics, 
dietary recall information, lab test results, and medical exam measurements for a nationally 
representative sample of the civilian non-institutionalized population for respondents over two 22 
     
months of age at the time of the survey.
13  We restrict our analysis to survey respondents over 
eighteen years of age, since BMI is not the standard metric used to diagnose childhood obesity.
14
We also use the public-use NHANES III Linked Mortality Files to examine the 
relationship between BMI-based obesity categories, various alternative measures of fatness 
(including %BF and WC), and the numerous causes of death associated with excess fat.  For 
those individuals 17 years of age or older at the time of the NHANES III interview, the file 
includes their individual mortality status (alive or deceased), the number of months since their 
interview, and (if deceased) the underlying cause of death (COD).  The follow-up period ended 
on December 31, 2006.  The Linked Mortality data set used the 10th revision of the International 
Statistical Classification of Diseases, Injuries, and Causes of Death (ICD-10) coding system to 
  
The use of a mobile examination center in NHANES III allowed for the collection of 
very detailed physical exam data.  The examiners conducted bioelectrical impedance analysis 
(BIA) for individuals 12 years and older, with the exception of pregnant women and individuals 
who had pacemakers, using the Valhalla 1990B Bio-Resistance Body Composition Analyzer.  
BIA measurements can be used to calculate fat-free mass (FFM) (i.e., the weight of everything in 
the body that is not fat tissue), and thus %BF, or the fraction of total weight composed solely of 
body fat (Kyle et al., 2004).  Table 3 displays selected summary statistics for adults surveyed in 
NHANES III.   
[TABLE 3. NHANES III Summary Statistics on BMI, Percent Body Fat, and Type 2 diabetes] 
                                                 
13 Detailed information on the survey design and methods used to conduct the NHANES III survey and the public 
use data files are available from the NCHS website: http://www.cdc.gov/nchs/nhanes/nhanes_questionnaires.htm. 
Race/ethnicity is self identified in the survey as white, black, other, or Mexican American of unknown race. 
14 Obesity status for children is only partially determined by BMI for age and gender percentiles.  Further testing and 
examination of diet and physical activity is needed to determine if a child is in fact carrying an unhealthy amount of 
body fat (Chinn, 2006). 23 
     
classify primary COD, and also indicates if diabetes, hip fracture, or hypertension was cited as a 
secondary COD.
15
B.  Calculation of Percent Body Fat  
   
Chumlea et al. (2002) used equations developed by Sun et al. (2003) from the NHANES 
III data to calculate measures of body composition, and described the distribution of %BF among 
the U.S. population.  We use the same body composition equations as Chumlea et al. (2002) to 
calculate %BF for all individuals in the survey for whom we had complete data on BIA and body 
weight.  We use equations (14) and (15) used to calculate FFM for males and females, 
respectively.   
 
2
10.678 0.262 0.652 0.015 Res
Res




Height FFM Weight   (14) 
 
2
9.529 0.168 0.696 0.016 Res
Res




Height FFM Weight   (15) 
where FFM and Weight is measured in kilograms, Height is measured in centimeters, and Res
RJL 
is a measure of electrical resistance in ohms.  We convert the BIA measurements obtained in the 
NHANES III physical exam from Valhalla resistance units to RJL resistance units for males and 




2.5 0.98 = +
RJL Valhalla
Male Res Res   (16) 
  9.6 0.96 = +
RJL Valhalla
Fem Res Res   (17) 
                                                 
15 The ICD-10 system includes 113 possible causes of death.  We group the 113 CODs into broader categories like 
heart disease, cancer, or respiratory disease. 
16 RJL and Valhalla are manufacturers of BIA devices.  Since the FFM equations in Chumlea et al. (2002) were 
estimated with RJL BIA resistance values, we had to convert the BIA measurements from NHANES III. 24 
     
We then calculate %BF as:  ( ) % 100* =− BF Weight FFM Weight . 
C.  Sampling and Replicate-Weighting Methods 
NHANES III used a complex sampling method and, for the estimates to represent the 
whole U.S. population, we must properly weight and adjust the data prior to any statistical 
analysis.  We use balanced repeated replication (BRR) methods, with the replicate and sampling 
weights included in the NHANES III data set, to account for the stratified sampling procedure 
and oversampling of specific subpopulations of interest.  We also use the “svy” commands in 
STATA to generate all the summary statistics and to estimate all regression equations. 
Sampling weights supplied in NHANES III take into account non-response bias, unequal 
sampling probability, and previously measured demographic information from the U.S. Census 
Bureau to ensure that the sample represents the U.S. population as a whole.  The sampling 
weight indicates the number of people in the U.S. population that a respondent represents.  In our 
analysis we apply the “MEC+Home” sample weights because we use data from both the mobile 
examination center and Household Survey portions of the data (Westat Inc., 1996). 
D.  Calculating Weight History Variables 
It takes multiple years of being obese to cause death or disease, but we observe only a 
snapshot in time.  We observe weight and disease status on the survey date, whether an 
individual died over the ensuing 12 to 18 years (depending on when they were surveyed) and, 
when one had died, the cause of death.     
To better capture the lagged effect of obesity on health outcomes, we use weight recall 
data.  We exploit the broad range of questions asked in the survey and knowledge about factors 25 
     
that influence the change of FFM within individuals over time to extend the follow-up period by 
ten years.  One of the many questions respondents were asked was: “what was your weight ten 
years ago?”  Individual FFM and individual gains in weight over a period of time are largely a 
function of gender, age, physical activity, menopausal status, and whether and for how long the 
individual had been using hormone replacement therapy drugs (Fukagawa, Bandini, and Young, 
1990; Poehlman et al., 1995; Guo et al., 1999; Kyle et al., 2001).  All of these characteristics can 
be deduced from information in NHANES III.  Using individual characteristics and self-reported 
weight ten years previously, we estimate (18) and calculated (19) and (20).
17
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PBF WtKgs   (20) 
These calculations allow us to classify individuals based on their current BMI and %BF, but also 
on the BMI and %BF ten years previously, assuming no change in height.  In essence, we extend 
the follow-up period by ten years and better capture the cumulative impact of excess body 
weight on morbidity and mortality. 
                                                 
17 The regression results for this model are available upon request. 26 
     
E.  Identifying Type 2 Diabetes and the Metabolic Syndrome 
  The NHANES III survey did not distinguish between type 1 and type 2 diabetes in the 
health questionnaire, therefore we employ the strategy used by Thompson et al. (1999) to 
identify individuals with type 2 diabetes.  We identify respondents as having type 2 diabetes if: 
(i) they reported having diabetes at any time other than during pregnancy (known as gestational 
diabetes), and they reported having been diagnosed with diabetes after age 30, or (ii) they were 
diagnosed as having diabetes between the ages of 18 and 30 years, and they were not taking 
insulin or they did not begin using insulin within one year of being diagnosed. 
  We use the International Diabetes Federation (IDF) definition of the metabolic syndrome 
to identify survey respondents who had the condition.  The IDF defines individuals as having the 
metabolic syndrome if they have a measured WC > 94 cm for men (> 80 cm for women) and at 
least two of the four following factors: (i) blood triglycerides ≥ 150 mg/dL or treatment for high 
triglycerides, (ii) high-density-lipoprotein (HDL or “good”) cholesterol < 40 mg/dL for men (< 
50 mg/dL for women) or treatment for low HDL, (iii) systolic blood pressure (BP) ≥ 130 mm 
Hg, diastolic BP ≥ 85 mm Hg, or treatment for high BP, and (iv) fasting plasma glucose ≥ 100 
mg/dL (IDF, 2006).  In our analysis, if a respondent was taking prescription medications to lower 
BP or cholesterol, then we define that respondent as having “treatment for” these conditions.  
The NHANES III Exam and Lab data files contain all the measurements and blood test results 
needed to identify the metabolic syndrome.   
VI.  Results 
To examine the value of BMI as a measure of disease risk and obesity we first estimate 
the measurement error associated with using BMI to predict obesity as measured by percent body 27 
     
fat.  Next, we construct our obesity index by combining information on the amount and location 
of body fat, weight history, and the metabolic abnormalities associated with obesity.  Then we 
assess the nature and extent of measurement error problems in models that use BMI instead of 
our index to predict the risk of death and disease.        
A.  Evaluation of BMI as a Proxy for Percent Body Fat as a Measure of Obesity 
  As outlined in section II, the elevated risk of disease and death associated with obesity 
largely stems from the metabolic complications that excess adipose tissue promotes.  We present 
in Table 4 results from regressions of %BF and BMI on a set of explanatory variables.  We also 
present results from the measurement error regression in (13). We use race, sex, age, smoking 
status, having reached menopause (for women), and years of hormone replacement therapy as 
explanatory variables.  Also, we model men and women separately because women need more 
body fat to initiate puberty and maintain fertility (Tataranni et al., 1997; Speakman, 2007).  The 
dichotomy in %BF for men and women appears in early childhood and should be controlled for 
(Pi-Sunyer, 1998).  A positive and significant coefficient on an explanatory variable (the Xs) in 
column (3), (6), or (9) implies that a model using BMI as a proxy for obesity would understate 
the effect of X on %BF. 
[TABLE 4. %BF Measurement Error Regressions] 
  The first column of Table 4 shows that women on average have %BF 11.3 percentage 
points higher than men.  However, the second column shows that women have very similar BMI 
levels.  Thus, we have a coefficient of 11.45 on the female dummy variable in the measurement 
error equation.  This result shows how using BMI in place of %BF would vastly understate 
differences in body fat.  For both men and women %BF increases with age, but this effect goes 28 
     
understated when using BMI as a proxy for %BF in women.  Similarly, black women have 
significantly higher %BF and BMI than white women, but the difference in %BF is relatively 
larger, so using BMI would understate the effect of race on obesity.   
The smoking variables correlate minimally with measurement error, especially for men.  
This result implies that smokers tend to have a lower %BF and a similarly lower BMI, and that 
regression models that relate smoking to obesity will generate similar results whether using BMI 
or %BF.  Women who take hormone replacement therapy (HRT) for longer time periods tend to 
have a lower BMI, but not a significantly lower %BF, so a model that uses BMI as a proxy for 
obesity will understate the effect of HRT on obesity. Thus, the apparent effect on obesity of this 
variable and any other variables correlated with it, would be spurious if the object of 
measurement is %BF.  We find little evidence of measurement error bias for family history of 
type 2 diabetes or insomnia. 
  BMI predicts %BF much better for women than men, a result also found by Burkhauser 
and Cawley (2008). The R
2 is 0.69 in the measurement error equation for women and only 0.39 
for men.  This difference implies that many men would be classified differently by BMI than by 
%BF.  We illustrate this point in Figure 3, which shows a scatter plot of %BF against BMI, along 
with the standard BMI classification cutoffs and %BF cutoffs based on predicted %BF (see 
Gallagher, 2000).  Figure 3 shows that almost 60 percent of men would be classified in a 
different obesity category if BMI were used in place of %BF.  Moreover, about 8 percent of men 
would be classified by BMI a full two obesity categories away from their %BF classification. 
Classification differences are smaller for women, with 45 percent misclassified by one category 
and about two percent misclassified by two categories. 29 
     
  [Figure 3. %BF vs. BMI Obesity Classification Matrix] 
B.  Evaluation of BMI as a Measure of Obesity for Predicting Health Outcomes 
We model the risk of type 2 diabetes, cardiovascular disease (CVD), death, and death 
from an obesity-related cause as a function of our obesity index or BMI.  In addition to 
information on weight history and the relative amount and location of body fat, our obesity index 
includes the degree of metabolic dysfunction present in an individual.  Including metabolic 
dysfunction is important because it is entirely possible for the metabolic and hormonal 
disruptions precipitated by excess body fat, especially visceral abdominal fat, to manifest in 
people with a normal BMI.  The phenomenon, referred to as metabolically obese normal weight 
(MONW) and first recognized in the 1980s, refers to individuals with elevated blood insulin 
(hyperinsulinemia) and insulin resistance (i.e., when the body requires more than the normal 
amount of insulin to elicit a normal metabolic response) (Ruderman et al., 1998).  Conversely, 
metabolically benign obesity or MBO (i.e., individuals with BMI ≥ 30 but who do not display 
insulin insensitivity) also exists (Stefan et al., 2008).  Thus, the health effects of obesity have 
multiple dimensions, and both the amount of body fat and the extent of metabolic dysfunction 
occurring in an individual play important roles in defining and describing obesity. 
We include several measures of metabolic dysfunction.  The variables TRGi, HDLi, and 
BPi are binary indicators that equal one in the event that individual i meets the criteria for 
metabolic syndrome with respect to that indicator.  For example, TRGi = 1 if individual i had 
blood triglycerides ≥ 150 mg/dL or received treatment for high triglycerides.  AbOBi is a binary 
indicator that equals one if individual i meets the IDF criteria for central obesity, i.e., WC > 
94cm for men and WC > 80 cm for women.  We also include four other variables: (i) the 
quantitative insulin sensitivity check index (QUICKI), (ii) an interaction between the binary 30 
     
indicator for high blood pressure (BP) and abdominal obesity (AbOB), (iii) an interaction 
between the binary indicator for high blood pressure (hypertension) and QUICKI, and (iv) an 
interaction between QUICKI and abdominal obesity (Katz et al., 2000; Quon, 2001).  We include 
the interactions because there is some evidence that insulin resistance and abdominal adiposity 
exacerbate hypertension and insulin resistance (Pi-Sunyer, 1998).  We also allow for the 
possibility of a non-linear relationship between current and lagged percent body fat (%BF and 
%BFt-10). 
The vector X contains measures of age, age squared, family history of type 2 diabetes, 
smoking status, alcohol intake, relative income, and sleep patterns.  Alcohol affects metabolism 
and nutrition in different ways depending on diet and the amount of alcohol consumed (Feinman 
and Lieber, 1998).  We include the percentage of daily calories (kcals) from alcohol and the 
percentage of daily calories from alcohol squared, as we expect the relationship between alcohol 
consumption and health risk to be J-shaped.  Relative income is measured as the ratio of annual 
household income to the poverty threshold, controlling for household size.  We identify an 
individual as having a family history of type 2 diabetes if the individual indicated that a mother, 
father, sibling, or a grandparent was ever told by a doctor that he or she had diabetes.     
We use a linear probability model framework to estimate our two competing models, as 
shown in Equations (21) and (22), using our obesity index versus BMI, respectively.  Equation 
(21) incorporates quadratic terms in %BF, %BFt-10, with interactions between %BF and race and 
sex.    31 
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The alternative model uses BMI in place of our obesity index, i.e., 
  ( )
10
01 2 3 Pr 1 ,
− ′ = =β +β +β +β +η +ε
t
i ii i i i i i D X F BMI Female Black X   (22) 
Equation (22) is a simple linear equation with no quadratic terms and no interactions between 
BMI and race and sex.  In either case, as health outcome measures we use type 2 diabetes, CVD, 
death during the follow-up period, and (given the individual died) death from an obesity-related 
cause. 
Table 5 displays the results for type 2 diabetes and CVD and Table 6 contains the results 
for death and death from an obesity-related cause.  Columns 2 and 6 of Tables 5 and 6 display 
the results from the model described by (21), and columns 3 and 7 display the results for (22).  
Columns 4 and 8 contain the difference in the estimated coefficients, or δ, on the explanatory 
variables, with the standard error of the difference in parentheses.  The asterisks in these columns 
indicate that the coefficients are statistically and significantly different from zero at the 1 (**) 
percent or 5 (*) percent level.  A statistically significant and positive estimate of δ implies that 
using BMI to predict health outcomes will result in an upward-biased estimate of the effect of the 
explanatory variables on the likelihood of having the health outcome.  To provide a benchmark, 
columns 1 and 5 contain the estimated effects of the explanatory variable on health outcomes 
independent from a measure of obesity.  We discuss the measurement error bias implied by our 32 
     
results before examining differences in classification of individuals between BMI and our 
obesity index.  
B.1.  Measurement Error Bias 
  Compared to BMI, our obesity index predicts a significantly larger share of the variation 
in type 2 diabetes: the fit of the model beyond the control variables improves 334 percent when 
we use our obesity index (the R
2 increases from 0.05 to 0.23).  The Vuong (1989) test statistic 
for non-nested hypotheses also indicates the model that uses our obesity index is better specified 
than one that includes BMI as a proxy for obesity.  The coefficients on the components of the 
obesity index take the expected signs and may give some insight into which components are 
relatively important for a particular health outcome.  For instance, insulin resistance (indicated 
by a lower QUICKI score), weight history, blood pressure, and the interaction between 
abdominal obesity and insulin resistance, are significant predictors of type 2 diabetes.  However 
cholesterol, triglycerides and weight history are relatively more important for predicting CVD.  
These insights are foregone in models that use BMI to predict health risk.   
[Table 5. BMI vs. Obesity Index Effects on Morbidity Outcomes] 
  When we use BMI to proxy for obesity, we find significant measurement error bias in (a) 
the estimated effect of aging on all four health outcomes, (b) the estimated effect of having a 
family history of type 2 diabetes on all four health outcomes, (c) the estimated effect of the 
percent of daily calories consumed in alcohol on all health outcomes except death during the 
follow up period, and (d) the estimated effect of income, as measured by the poverty income 
ratio, on all health outcomes except cardiovascular disease.   33 
     
  We obtain positive values of δ for age and family history of diabetes, which implies that 
using BMI when modeling or predicting type 2 diabetes risk leads to an upward-biased estimate 
of the effect of these variables on type 2 diabetes risk and a corresponding downward-biased 
estimate of the effect of obesity on type 2 diabetes risk.  Specifically, a model using BMI would 
overstate by 0.03 the impact of a family history of diabetes on the probability of getting diabetes 
and understate by 0.03 the impact of obesity on getting diabetes.  The BMI model would falsely 
attribute more blame for the disease to family history and less to obesity than it should.  Given 
that 10 percent of our sample has type 2 diabetes, this prediction error of 3 percentage points is 
substantial.  
Similarly, a model using BMI will overestimate the effect of being age 60 rather than 30 
on type 2 diabetes risk by 8 percentage points ((60-30)*[0.003]-(60-30)
2[0.00001] = 0.08).  The 
model substantially overstates the effect of aging on the probability of getting type 2 diabetes 
and understates the effect of obesity as measured by our index.  This difference arises because 
BMI does not capture changes in body chemistry that increasingly affect the health of obese 
people as they age.  It implies that researchers should be careful in interpreting estimated effects 
on obesity of variables that are correlated with age. 
  Table 5 also shows that a model using BMI would find more negative the effect of 
household income and daily alcohol intake on diabetes risk and correspondingly find less 
negative the effect of these variables on obesity.  For instance, a model using BMI to predict type 
2 diabetes risk will overestimate by 2.5 percentage points the decrease in type 2 diabetes risk 
associated with increasing the share of daily calories from alcohol from 0 to 15 percent.  This 
difference arises because alcohol consumption has a miniscule effect on diabetes risk in the 
obesity index model and a negative coefficient in the model containing BMI.  34 
     
Similarly, household income has a negative coefficient in the model with BMI and a 
small insignificant coefficient in the obesity index model.  The δ estimate of -0.003 on the 
Income-Poverty ratio implies that using BMI would lead to a researcher overstating by 1 
percentage point the negative effect on diabetes risk of an income four times the poverty line 
compared to an income at the poverty line.  Correspondingly, the researcher would understate the 
negative effect of larger income on obesity.  To look at it another way, the negative relationship 
between income and diabetes risk in column (1) of Table 5 disappears when we use our obesity 
index, but not when we use BMI to measure obesity; the measurement error in BMI is correlated 
with household income in a small but statistically significant way.  This result is consistent with 
a finding in Burkhauser and Cawley (2008) that body fat correlates more strongly with 
employment than does fat-free mass. 
  Relative to BMI, our obesity index produces a small improvement in fit for CVD, 
although the Vuong test indicates that the improvement is statistically significant.  As with type 2 
diabetes risk, models using BMI to predict CVD overstate the effect of age on health and 
therefore understate the effect of age on obesity.  Using BMI also inflates the effect of being an 
ex-smoker on CVD risk and correspondingly deflates the effect of being an ex-smoker on 
obesity-related CVD risk.  For instance, a model that predicts CVD using BMI will overstate the 
effect of being an ex-smoker by 0.7 percentage points.  On the other hand, a model that predicts 
CVD using BMI will overestimate the negative effect of alcohol by 3 percentage points for a 25 
percentage point increase in the share of calories from alcohol. 
  In our obesity index, variables representing weight history, high blood pressure, insulin 
resistance, and interaction between insulin resistance and high blood pressure components 35 
     
significantly predict death during the follow up period.
18
B.2.  Classifying Individuals Using Our Obesity Index 
  Our obesity index predicts death 
during the follow-up period only marginally better than BMI, but the Vuong tests imply the 
models containing our obesity index are better specified than the models using BMI.  We find 
significant measurement error bias associated with age, family history, and the income-poverty 
ratio for death and for death from an obesity-related cause.  We do not find significant 
measurement error bias associated with being a current or former smoker in models that use BMI 
to predict mortality and obesity-related mortality risk.  The results imply that predicting mortality 
and death from an obesity-related cause with BMI will overstate the effect of age on mortality 
risk.  For example, a model that uses BMI to predict mortality risk will overstate the effect of a 
20-year age difference by 3 percentage points.  Similarly, a model that uses BMI to predict the 
risk of death from an obesity-related cause will understate the effect of a 20-year age difference 
by 10.3 percentage points. 
[Table 6. BMI vs. Obesity Index Effects on Mortality Outcomes] 
Because obesity is the major cause of diabetes, but one of many causes of CVD and 
death, the differences between BMI and our obesity index are most stark in the case of diabetes. 
These differences produce errors in prediction of the prevalence of disease among those who 
have it and those who do not.  In Table 7, Panel A shows the distribution of the predicted 
probability of having type 2 diabetes for all individuals in the sample from the model using our 
obesity index (i.e., calculated using the estimated coefficients in Equation (21)).  Panel B shows 
the corresponding distribution of the predicted probability from the model using BMI instead 
                                                 
18 The negative coefficient on QUICKI implies a decrease insulin resistance, or an increase in QUICKI results in a 
lower risk of death.  Similarly, decreasing insulin resistance when one has high blood pressure results in a decreased 
risk of death.    36 
     
(i.e., using the estimated coefficients in Equation (22)).  We calculate these probabilities at the 
mean of the explanatory variables (X) so as to isolate the effect of the obesity variables.  The first 
row in Panel A (or B) of Table 7 describes the share of all non-diabetic respondents (90 percent 
of all respondents) who had a predicted probability of type 2 diabetes less than 10 percent, 
between 10 and 25 percent, between 25 and 50, or more than 50 percent using our obesity index 
(or BMI).  The second row of Panel A (or B) of Table 7 contains the distribution of predicted 
type 2 diabetes risk for diagnosed diabetics (the remaining 10 percent of respondents).   
Of the 90 percent of individuals in the sample who were non-diabetic, in Panel A (using 
our obesity index), 65.1 percent had a predicted probability of type 2 diabetes of less than 0.1, 
and a further 30.2 percent had a predicted probability of type 2 diabetes of between 0.1 and 0.25.  
In contrast, in Panel B (using BMI), 72.9 percent had a predicted probability of type 2 diabetes of 
less than 0.1, and a further 27.0 percent had a predicted probability of type 2 diabetes of between 
0.1 and 0.25.  Thus, our obesity index predicts a less than 25 percent risk of type 2 diabetes in 
95.3 percent of non-diabetics whereas BMI predicts a less than 25 percent risk in 100 percent of 
non-diabetics.  In this sense, the model based on BMI has a slightly lower propensity for false 
positives.   
False negatives possibly generate more concern than false positives.  The model based on 
BMI predicts less than 10 percent risk of diabetes for 59 percent of diagnosed diabetics, whereas 
our obesity-index model predicts such low risk for just 9 percent of diabetics. For all diabetics, 
the BMI model predicts less than 25 percent risk, but only 45 percent of diabetics receive this 
low-risk prediction from the obesity-index model. Our obesity index produces a much lower 
propensity for false negatives.   37 
     
  The superior ability of our obesity index to predict a significant type 2 diabetes risk in the 
diabetic is further illustrated in Figure 4.  The horizontal axis displays the predicted type 2 
diabetes risk using BMI and the vertical axis displays the predicted risk using our obesity index.  
The open circles indicate diagnosed diabetics and the crosses indicate non-diabetics.  If the 
model using BMI could predict perfectly, then all the crosses would be at the value 0 at the left 
edge of the figure and all the circles would be at the value 1 on the right.  Similarly, if our 
obesity index could predict perfectly, then all the crosses would be at the value 0 at the bottom of 
the figure and all the circles would be at the value 1 on the top.  The observations lying above the 
45 degree line have a greater predicted type 2 diabetes risk from our obesity index than using 
BMI.  The figure shows that almost all diabetics are reported above the 45 degree line, implying 
our obesity index predicts a higher type 2 diabetes risk for these individuals than does BMI.  
[TABLE 7.  Actual Diabetes Status and Predicted Diabetes Status]  
[FIGURE 4. BMI vs. the Obesity Index Predicted Risk of Type 2 Diabetes]  
VII.  Conclusion 
In this paper we review and evaluate the use of BMI to identify the causes and predict the 
consequences of obesity.  We use a flexible function of percent body fat and several metabolic 
factors to construct an obesity index, which we use to evaluate BMI.  We find that economic 
research that uses BMI to proxy for obesity may suffer from significant measurement error bias.  
Models that use BMI without controlling for age, family medical history, household income, and 
alcohol consumption may generate significantly biased estimates of the causes and effects of 
obesity.  We find particularly large differences in how aging correlates with BMI versus our 38 
     
obesity index.  Ignoring these drawbacks of BMI could lead to misguided policy if researchers 
attribute the health and economic effects of obesity falsely to other variables.  
Our results do not imply that BMI is irrelevant as an obesity measure.  Most individuals 
with high BMI also have high levels of body fat and face obesity-related health risks (see Figure 
3). BMI is also easy to calculate because it requires only weight and height measurements. 
However, our obesity index suggests ways to create more refined measures of obesity.  In 
particular, we suggest further research into the use of measures of insulin resistance, blood 
pressure, and waist circumference in measuring obesity. 39 
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c   Not Obese 
 
Obese 
Male  <25% 
 
≥25% 





              Male  <90 cm 
 
≥90 cm 
Female  <84 cm     ≥84 cm 
c: These are the NIH and NIDDK recommended %BF cutoffs. 
a: These are the %BF cutoffs suggested in Gallagher et al. (2000), based on BMI cutoffs. 
b: These are the WC cutoffs used by the American Heart Association. 
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                %BF
a  Not Obese 
 
Obese 
Male  55.09 
 
44.91 





              Male  37.54 
 
62.46 
Female  41.63 
 
58.37 
1: These are based on the NIH and NIDDK recommended %BF cutoffs, which only distinguish 
between obese and non-obese. 
2: The %BF cutoffs suggested in Gallagher et al. (2000), based on BMI cutoffs. 
3: The WC cutoffs used by the American Heart Association. 
4: The WC cutoffs suggested in Zhu et al. (2002), which only distinguish between two weight 
categories: obese and non-obese. 
Notes: All frequencies were calculated using STATA “svy” command for individuals 18 years of 
age and older for whom a waist circumference measurement was taken.  A total of 7,739 men and 






     
 
Table 3.  BMI, Percent Body Fat, and Type 2 Diabetes Summary Statistics 
 






18-30 years  30-60 years  Over 60 years 
 
18-30 years  30-60 years  Over 60 years  
Type 2 Diabetes Prevalence (%)  0.2  3.2  10.7 
 
0.4  5.1  21.3 
Percent Body Fat (%)  31.4  35.2  36.3 
 
35.0  38.8  38.7 
BMI (kg/m
2)  23.8  26.7  26.8 
 
25.8  29.5  29.2 
No. of  observations  1,111  2,402  1,854 
 
657  1,249  472 
               
 






18-30 years  30-60 years  Over 60 years 
 
18-30 years  30-60 years  Over 60 years  
Type 2 Diabetes Prevalence (%)  0.4  4.1  11.4 
 
0.7  4.6  15.4 
Percent Body Fat (%)  21.7  24.4  25.5 
 
22.9  24.3  24.3 
BMI (kg/m
2)  24.9  27.1  27.0 
 
25.7  26.6  26.3 
No. of  observations  1,178  2,193  1,779 
 
602  1,017  457 
Note: Those with type 2 diabetes are identified using the method outlined in Thompson et al. (1999).  
Source:  NHANES III.    50 
     







Dependent Variable:  %BF  BMI  %BF 
 
%BF  BMI  %BF 
 
%BF  BMI  %BF 
 
(1)  (2)  (3) 
 
(4)  (5)  (6) 
 
(7)  (8)  (9) 
Regressors 
                      BMI 
   
0.89** 
     
0.94** 
     
0.77** 
     
(0.02) 
     
(0.03) 
     
(0.03) 
Female  11.28**  -0.19  11.45** 
               
 
(0.19)  (0.16)  (0.16) 
                Age  0.54**  0.36**  0.23** 
 
0.55**  0.37**  0.21** 
 
0.29**  0.24**  0.11 
 
(0.06)  (0.05)  (0.05) 
 
(0.09)  (0.08)  (0.07) 
 
(0.08)  (0.07)  (0.08) 
Age
2  -0.0045**  -0.00**  -0.0017** 
 
-0.0049**  -0.00** -0.0017** 
 
-0.0024**  -0.00**  -0.0006 
 
(0.00)  (0.00)  (0.00) 
 
(0.00)  (0.00)  (0.00) 
 
(0.00)  (0.00)  (0.00) 
Black  2.06**  1.56**  0.67** 
 
3.33**  2.69**  0.80** 
 
0.30  -0.02  0.31 
 
(0.29)  (0.21)  (0.15) 
 
(0.35)  (0.31)  (0.22) 
 
(0.33)  (0.23)  (0.23) 
Current Smoker  -1.43**  -1.15**  -0.41* 
 
-1.82**  -1.33**  -0.57* 
 
-1.21**  -1.03**  -0.41 
 
(0.24)  (0.16)  (0.21) 
 
(0.34)  (0.23)  (0.26) 
 
(0.32)  (0.27)  (0.32) 
Ex-Smoker  0.68**  0.65**  0.11 
 
0.78*  0.67  0.15 
 
0.67**  0.74**  0.01 
 
(0.19)  (0.18)  (0.18) 
 
(0.31)  (0.36)  (0.25) 
 
(0.24)  (0.24)  (0.28) 
Alcohol Calorie Share  -0.04  -0.09**  0.03 
 
-0.19**  -0.18**  -0.01 
 
-0.01  -0.06*  0.03 
 
(0.03)  (0.02)  (0.03) 
 
(0.05)  (0.04)  (0.03) 
 
(0.03)  (0.02)  (0.03) 
(Alcohol Calorie Share)
2  0.0003  0.00  -0.0009 
 
0.0065**  0.01**  0.0015 
 
-0.0007  0.00  -0.0012 
 
(0.00)  (0.00)  (0.00) 
 
(0.00)  (0.00)  (0.00) 
 
(0.00)  (0.00)  (0.00) 
Menopause 
       
2.28**  1.77**  0.63* 
       
         
(0.42)  (0.37)  (0.31) 
        < 5 Yrs HRT 
       
-0.57  -1.00*  0.37 
       
         
(0.43)  (0.39)  (0.27) 
        > 5 Yrs HRT 
       
-0.35  -1.35**  0.91** 
       
         
(0.46)  (0.39)  (0.29) 
        Family History of Type 2 Diabetes  1.11**  1.24**  0.01 
 
1.43**  1.53**  -0.0074 
 
0.63*  0.83**  -0.01 
 
(0.20)  (0.14)  (0.15) 
 
(0.22)  (0.19)  (0.19) 
 
(0.27)  (0.18)  (0.24) 
Insomnia Spells  1.74*  1.19**  0.69 
 
2.03  1.95**  0.20 
 
0.85  -0.07  0.91 
 
(0.71)  (0.43)  (0.49) 
 
(1.02)  (0.68)  (0.64) 
 
(0.79)  (0.53)  (0.68) 
Hypersomnia Spells  -0.88  -0.18  -0.72 
 
-0.43  0.32  -0.73 
 
-0.61  -0.98  0.14 
 
(1.12)  (0.83)  (0.73) 
 
(1.38)  (1.02)  (0.82) 
 
(0.99)  (1.25)  (1.22) 
Constant  8.93**  17.32**  -6.41** 
 
19.70**  16.36**  4.36* 
 
16.39**  21.28**  0.03 
 
(1.83)  (1.54)  (1.45) 
 
(2.72)  (2.19)  (2.08) 
 
(2.28)  (2.17)  (2.20) 
Observations  7,826  7,826  7,826 
 
4,012  4,012  4,012 
 
3,814  3,814  3,814 
R
2  0.45  0.05  0.76 
 
0.08  0.07  0.69 
 
0.03  0.05  0.39 
Null F-Stat 
   
21.91 
     
18.63 
     
7.67 
Null p-value        0.00           0.00           0.00 




     
Table 5.  BMI vs. Obesity Index Effects on Type 2 Diabetes and CVD 
 




(1)  (2)  (3)  δ=(3)-(2) 
 
(5)  (6)  (7)  δ=(7)-(6) 
BMI 
   
0.006** 
       
0.003** 
 
     
(0.001) 
       
(0.001) 
  %BF 
 
-0.006 
       
0.001 
   
   
(0.004) 
       
(0.011) 




       
0.00001 
   
   
(0.000) 
       
(0.000) 
    %BFt-10 
 
0.001 
       
-0.004* 
   
   
(0.001) 
       
(0.001) 
    (%BFt-10)2 
 
0.00007** 
       
0.00006* 
   
   
(0.000) 
       
(0.000) 
    Female*%BF 
 
0.005 
       
-0.002 
   
   
(0.005) 
       
(0.011) 




       
0.00000 
   
   
(0.000) 
       
(0.000) 
    Black*%BF 
 
-0.007 
       
-0.007 
   
   
(0.004) 
       
(0.005) 




       
0.00011 
   
   
(0.000) 
       
(0.000) 
    Waist Circumference 
 
0.001* 
       
-0.001 
    Criteria for Metabolic Syndrome Dummies: 
 
(0.001) 
       
(0.001) 
       Triglycerides 
 
-0.012* 
       
0.026* 
   
   
(0.005) 
       
(0.010) 
       HDL Cholesterol 
 
0.001 
       
0.046** 
   
   
(0.007) 
       
(0.006) 
       Blood Pressure 
 
0.625** 
       
0.492** 
   
   
(0.122) 
       
(0.102) 
    QUICKI 
 
-5.450** 
       
0.162 
   
   
(0.485) 
       
(0.454) 
    (Blood Pressure)*(QUICKI) 
 
-4.025** 
       
-3.074** 
   
   
(0.773) 
       
(0.645) 
    (Abdominal Obesity)*(QUICKI) 
 
-0.143* 
       
0.049 
   
   
(0.062) 
       
(0.093) 
    (Blood Pressure)*(Abdominal Obesity) 
 
-0.038** 
       
-0.032 
   
   
(0.012) 
       
(0.019) 
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Table 5 (continued).  BMI vs. Obesity Index Effects on Type 2 Diabetes and CVD 
 




(1)  (2)  (3)  δ=(3)-(2) 
 
(5)  (6)  (7)  δ=(7)-(6) 
Female  -0.022**  -0.001  -0.021*  -0.020 
 
-0.043**  0.005  -0.042**  -0.048 
 
(0.006)  (0.079)  (0.009)  (0.100) 
 
(0.010)  (0.142)  (0.010)  (0.143) 
Black  0.031**  0.095  0.023*  -0.072 
 
-0.010  0.087  -0.014  -0.101 
 
(0.008)  (0.062)  (0.009)  (0.071) 
 
(0.009)  (0.079)  (0.011)  (0.093) 
Age  0.009**  0.004*  0.007**  0.003** 
 
0.007**  0.004  0.006  0.002** 
 
(0.002)  (0.002)  (0.003)  (0.001) 
 
(0.002)  (0.002)  (0.003)  (0.001) 
Age
2  -0.00006**  -0.00002  -0.00003  -0.00001 
 
-0.00002  0.00001  -0.00001  -0.00002** 
 
(0.000)  (0.000)  (0.000)  (0.00000) 
 
(0.000)  (0.000)  (0.000)  (0.00001) 
Current Smoker  -0.009  -0.004  -0.002  0.002 
 
0.041**  0.040**  0.045**  0.005 
 
(0.008)  (0.008)  (0.011)  (0.005) 
 
(0.009)  (0.008)  (0.013)  (0.003) 
Former Smoker  0.018*  0.001  0.014  0.006 
 
0.040**  0.031**  0.038**  0.007** 
 
(0.007)  (0.007)  (0.010)  (0.004) 
 
(0.009)  (0.009)  (0.012)  (0.002) 
Alcohol Calorie Share  -0.002**  -0.000  -0.002*  -0.002** 
 
-0.001  -0.000  -0.001  -0.001** 
 
(0.001)  (0.001)  (0.001)  (0.000) 
 
(0.001)  (0.001)  (0.001)  (0.000) 
(Alcohol Calorie Share)
2  0.00003*  0.00001  0.00002  -0.00167 
 
-0.00001  -0.00002  -0.00001  -0.00100 
 
(0.000)  (0.000)  (0.000)  (0.00042) 
 
(0.000)  (0.000)  (0.000)  (0.00031) 
Family History Type 2 Diabetes  0.078**  0.048**  0.071**  0.023** 
 
0.034**  0.021*  0.030**  0.009** 
 
(0.010)  (0.008)  (0.008)  (0.004) 
 
(0.009)  (0.009)  (0.011)  (0.002) 
Income-Poverty Ratio  -0.004**  0.00001  -0.003  -0.003** 
 
-0.015**  -0.014**  -0.015**  -0.001 
 
(0.001)  (0.002)  (0.002)  (0.001) 
 
(0.002)  (0.002)  (0.003)  (0.000) 
Insomnia Spells  0.056**  0.050**  0.050  0.000 
 
0.058  0.051  0.055  0.004 
 
(0.020)  (0.017)  (0.040)  -- 
 
(0.029)  (0.029)  (0.037)  (0.005) 
Hypersomnia Spells  -0.007  -0.007  -0.006  0.002 
 
0.071  0.073  0.071  -0.002 
 
(0.019)  (0.023)  (0.028)  (0.016) 
 
(0.050)  (0.048)  (0.059)  (0.005) 
Constant  -0.277**  0.684**  -0.381** 
   
-0.166**  -0.083  -0.219* 
 
 
(0.052)  (0.125)  (0.075) 
   
(0.059)  (0.175)  (0.086) 
  Observations  7,826  7,826  7,826 
   
7,826  7,826  7,826 
  R-squared  0.053  0.230  0.069 
   
0.058  0.080  0.060 
  Ho: Equivalence of Xs in Obesity Index and BMI 
                  F-Stat 
     
9.595 
       
4.051 
p-value 
     
0.000 
       
0.000 
Ho: Obesity Index model better specified than BMI model 
                Vuong test statistics 
   
16.601 
       
5.859 
  p-value        0.000              0.000    
Notes: Standard errors in parentheses, ** p<0.01, * p<0.05 
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Death from an Obesity-Related COD 
 
(1)  (2)  (3)  δ=(3)-(2) 
 
(5)  (6)  (7)  δ=(7)-(6) 
BMI 
   
0.002* 
       
0.009** 
 
     
(0.001) 
       
(0.003) 
  %BF 
 
-0.004 
       
0.016 
   
   
(0.007) 
       
(0.019) 




       
-0.00029 
   
   
(0.000) 
       
(0.000) 
    %BFt-10 
 
-0.001 
       
-0.003 
   
   
(0.001) 
       
(0.003) 
    (%BFt-10)2 
 
0.00006** 
       
0.00007 
   
   
(0.000) 
       
(0.000) 
    Female*%BF 
 
-0.006 
       
-0.005 
   
   
(0.009) 
       
(0.023) 




       
0.00013 
   
   
(0.000) 
       
(0.000) 
    Black*%BF 
 
-0.009 
       
0.001 
   
   
(0.006) 
       
(0.012) 




       
0.00004 
   
   
(0.000) 
       
(0.000) 
    Waist Circumference 
 
0.000 
       
0.003 
    Criteria for Metabolic Syndrome Dummies: 
 
(0.001) 
       
(0.002) 
       Triglycerides 
 
-0.016 
       
0.04724 
   
   
(0.009) 
       
(0.031) 
       HDL Cholesterol 
 
-0.004 
       
0.069* 
   
   
(0.011) 
       
(0.026) 
       Blood Pressure 
 
0.371** 
       
0.321 
   
   
(0.123) 
       
(0.295) 
    QUICKI 
 
-0.731* 
       
0.704 
   
   
(0.360) 
       
(1.427) 
    (Blood Pressure)*(QUICKI) 
 
-2.148** 
       
-1.174 
   
   
(0.754) 
       
(1.973) 
    (Abdominal Obesity)*(QUICKI) 
 
-0.176 
       
0.099 
   
   
(0.090) 
       
(0.405) 
    (Blood Pressure)*(Abdominal Obesity) 
 
-0.010 
       
-0.107 
   
   
(0.022) 
       
(0.058) 
       54 
     




Death from an Obesity-Related COD 
 
(1)  (2)  (3)  δ=(3)-(2) 
 
(5)  (6)  (7)  δ=(7)-(6) 
Female  -0.053**  0.090  -0.052**  -0.142 
 
0.041  0.093  0.038  -0.054 
 
(0.009)  (0.123)  (0.010)  (0.149) 
 
(0.030)  (0.339)  (0.030)  (0.122) 
Black  0.034**  0.205*  0.031**  -0.174 
 
0.078**  0.030  0.077*  0.047 
 
(0.009)  (0.091)  (0.011)  (0.103) 
 
(0.027)  (0.190)  (0.030)  (0.117) 
Age  -0.030**  -0.032**  -0.031**  0.001* 
 
-0.003  -0.010  -0.005  0.005** 
 
(0.002)  (0.003)  (0.003)  (0.001) 
 
(0.008)  (0.008)  (0.011)  (0.002) 
Age
2  0.00041**  0.00042**  0.00042**  0.00000 
 
0.00005  0.00010  0.00007  -0.00003 
 
(0.000)  (0.000)  (0.000)  (0.00000) 
 
(0.000)  (0.000)  (0.000)  (0.00001) 
Current Smoker  0.134**  0.135**  0.137**  0.001 
 
-0.119**  -0.109**  -0.096*  0.012 
 
(0.011)  (0.010)  (0.014)  (0.003) 
 
(0.036)  (0.034)  (0.041)  (0.007) 
Former Smoker  0.045**  0.042**  0.044**  0.002 
 
-0.05422  -0.066*  -0.055  0.011 
 
(0.011)  (0.011)  (0.011)  (0.002) 
 
(0.031)  (0.031)  (0.034)  (0.007) 
Alcohol Calorie Share  -0.001  -0.000  -0.001  0.000 
 
-0.006  -0.005  -0.006  -0.001* 
 
(0.001)  (0.001)  (0.001)  (0.000) 
 
(0.004)  (0.003)  (0.005)  (0.000) 
(Alcohol Calorie Share)
2  0.00001  -0.00000  0.00000  0.00000 
 
0.00018  0.00016  0.00018  -0.00100 
 
(0.000)  (0.000)  (0.000)  (0.00026) 
 
(0.000)  (0.000)  (0.000)  (0.00050) 
Family History Type 2 Diabetes  0.007  -0.003  0.004  0.007** 
 
0.063*  0.043  0.054  0.011** 
 
(0.008)  (0.009)  (0.010)  (0.002) 
 
(0.025)  (0.024)  (0.029)  (0.003) 
Income-Poverty Ratio  -0.01991**  -0.01776**  -0.01942**  -0.002** 
 
0.007  0.009  0.008  -0.001** 
 
(0.002)  (0.002)  (0.003)  (0.000) 
 
(0.006)  (0.006)  (0.008)  (0.000) 
Insomnia Spells  0.009  0.006  0.006  0.000 
 
-0.337**  -0.309**  -0.322**  -0.015 
 
(0.015)  (0.016)  (0.019)  -- 
 
(0.074)  (0.091)  (0.085)  (0.033) 
Hypersomnia Spells  -0.018  -0.019  -0.018  0.001 
 
0.021  0.002  0.015  0.013 
 
(0.012)  (0.013)  (0.016)  (0.005) 
 
(0.218)  (0.182)  (0.217)  (0.015) 
Constant  0.606**  0.796**  0.570** 
   
0.479  0.018  0.262 
 
 
(0.064)  (0.111)  (0.080) 
   
(0.262)  (0.451)  (0.359) 
  Observations  7,826  7,826  7,826 
   
2,536  2,536  2,536 
  R-squared  0.357  0.369  0.357 
   
0.036  0.060  0.044 
  Ho: Equivalence of Xs in Obesity Index and BMI 
                  F-Stat 
     
3.423 
       
1.369 
p-value 
     
0.000 
       
0.173 
Ho: PSA Obesity Index model better specified than BMI model 
                Vuong test statistics 
   
6.168 
       
3.127 
  p-value        0.000              0.002    
Standard errors in parentheses, ** p<0.01, * p<0.05 
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p < 0.1  0.1 ≤ p < 0.25  0.25 ≤ p < 0.5  p ≥ 0.5 
 
 
Panel A: Our Obesity Index 
 
         
Row Total 
Non-Diabetic   0.651  0.302  0.047  0.001  0.900 
Diabetic  0.090  0.360  0.480  0.070  0.100 
           
           
 
Panel B: Body Mass Index  Row Total 
Non-Diabetic  0.729  0.270  0.000  0.000  0.900 
Diabetic  0.590  0.410  0.000  0.000  0.100 
 
 56 










































Figure 1: Mechanics of Excess Adipose Tissue and Disease Risk.   
Adapted from figures and results in Calle and Kaaks (2004), Van Gaal, Mertens, 
and De Block (2006), and Plagemann (2008). 57 
     
 
Estimated effect of  
X on Health 
outcomes biased 
upward 
Estimated effect of  
X on obesity biased 
downward 
Figure 2: Interpretation of Measurement Error Bias δ > 0. 58 
     
 
Figure 3. %BF vs. BMI Obesity Classification Matrix 59 











































































Note: Prediction at the mean of the explanatory variables














Figure 4. BMI vs. Our Obesity Index Predicted Probability of Type 2 Diabetes  